Bank of Hawaii’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$306K Sell
8,313
-32
-0.4% -$1.52K 0.02% 197
2025
Q4
$425K Buy
8,345
+3,727
+81% +$191K 0.02% 193
2025
Q3
$256K Buy
+4,618
New +$270K 0.01% 220
2020
Q1
Sell
-10,034
Closed -$290K 317
2019
Q4
$290K Buy
+10,034
New +$278K 0.02% 294
2019
Q3
Sell
-10,428
Closed -$266K 343
2019
Q2
$266K Sell
10,428
-30,044
-74% -$743K 0.02% 294
2019
Q1
$1.06M Sell
40,472
-34,368
-46% -$845K 0.08% 150
2018
Q4
$1.72M Sell
74,840
-3,804
-5% -$84.5K 0.15% 99
2018
Q3
$1.85M Buy
78,644
+686
+0.9% +$16.7K 0.14% 105
2018
Q2
$1.8M Sell
77,958
-1,478
-2% -$35.1K 0.15% 101
2018
Q1
$1.96M Buy
79,436
+7,756
+11% +$204K 0.16% 101
2017
Q4
$1.92M Buy
71,680
+376
+0.5% +$9.56K 0.16% 100
2017
Q3
$1.72M Buy
71,304
+18,982
+36% +$429K 0.14% 113
2017
Q2
$1.12M Buy
52,322
+5,784
+12% +$117K 0.1% 147
2017
Q1
$798K Buy
46,538
+5,234
+13% +$91.1K 0.07% 177
2016
Q4
$741K Buy
41,304
+2,700
+7% +$48.9K 0.07% 182
2016
Q3
$803K Sell
38,604
-656
-2% -$16.3K 0.07% 180
2016
Q2
$1.06M Buy
39,260
+9,320
+31% +$256K 0.11% 146
2016
Q1
$811K Buy
+29,940
New +$802K 0.09% 172

Other funds holding NVO

Bank of Hawaii's NVO Position: Q1 2026 in Review

Bank of Hawaii reduced its Novo Nordisk (NVO) stake by 0.38% in Q1 2026, selling an estimated $1.52K and leaving 8,313 shares worth $306K. The position accounts for 0.02% of the portfolio, ranked #197.

Bank of Hawaii first reported a position in NVO in Q1 2016 and has held it in 18 quarters since. The position peaked at $1.96M in Q1 2018. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Bank of Hawaii held 8,313 shares of Novo Nordisk worth $306K as of Q1 2026.
  • Bank of Hawaii sold 32 Novo Nordisk shares in Q1 2026, an estimated $1.52K.
  • Novo Nordisk made up 0.02% of Bank of Hawaii's portfolio in Q1 2026, its #197 holding.
  • Bank of Hawaii first reported a position in Novo Nordisk in Q1 2016 and has held it in 18 quarters since.
  • Bank of Hawaii's Novo Nordisk position peaked at $1.96M in Q1 2018.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Bank of Hawaii's 13F filing for Q1 2026, filed 15 May 2026.